Related Experiment Video
Updated: Apr 10, 2026
07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
6.3K
Genome-Wide Scan for Methylation Profiles in Keloids
Lamont R Jones1, William Young2, George Divine3
1Department of Otolaryngology-Head and Neck Surgery, Henry Ford Hospital, Detroit, MI 48202, USA.
Disease Markers
|June 16, 2015
Summary
Keloid research reveals epigenetic changes, specifically DNA methylation patterns, play a key role in keloid formation. This study highlights a predominance of hypomethylated genomic landscapes in keloids, suggesting new therapeutic targets.
Area of Science:
- Dermatology
- Epigenetics
- Genomics
Background:
- Keloids are benign skin tumors often recurring after injury, particularly in individuals with darker skin.
- Current medical treatments have high recurrence rates due to limited understanding of keloid biological mechanisms.
Purpose of the Study:
- To investigate keloid pathogenesis by examining DNA methylation patterns from an epigenome perspective.
- To identify differentially methylated genes associated with keloid formation.
Main Methods:
- Genome-wide DNA methylation profiling using the Infinium HumanMethylation450 BeadChip.
- Analysis of DNA from 6 keloid and 6 normal skin samples.
- A tiered approach to identify differentially methylated CpGs (cytosine methylation sites) and associated genes.
Main Results:
- Identified 685 differentially methylated CpGs between keloid and normal skin, with a majority (510) being hypomethylated.
- Observed a predominance of hypomethylated genomic landscapes, particularly in non-promoter regions.
- Found 152 genes with promoter region CpGs differentially methylated, with 63% being hypomethylated.
Conclusions:
- DNA methylation is a significant mechanism regulating gene expression in keloid pathogenesis.
- The predominance of hypomethylation suggests potential novel therapeutic strategies targeting epigenetic modifications.
- Epigenetic regulation offers an alternative explanation for keloid formation beyond genetic mutations.
